344 results
8-K
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
30 May 24
Other Events
4:03pm
of $75 million. The closing was subject to the satisfaction of customary closing conditions, including execution of customary ancillary documents
8-K
EX-10.1
l5luu9rnivkw6vnm8g
17 Oct 23
Entry into a Material Definitive Agreement
7:24pm
8-K
EX-10.1
lmphoxu9tze
4 Nov 22
Unaudited Pro Forma Condensed Consolidated Financial Statements
4:08pm
425
pmjlc5
3 Oct 22
Business combination disclosure
9:20am
8-K
EX-99.1
1nefw662q 875qct6r
3 Oct 22
Ligand Announces Record Date and Details for Distribution for OmniAb Spin-Off
9:18am
S-3ASR
EX-4.3
l2mz9v1h4cu4z1mxahu
30 Sep 22
Automatic shelf registration
4:17pm
S-3ASR
EX-1.2
yev6aks92
30 Sep 22
Automatic shelf registration
4:17pm
S-8
EX-10.2
i2w5ms83h6st9 xb9fw
13 Jun 22
Registration of securities for employees
8:44am